In a 59-year-old male with left posterior soft tissue masses that ultrasound suggests are lipomas, should I wait to obtain an MRI with and without contrast before proceeding with further management?

Should You Wait for MRI Before Proceeding?

No, you do not need to wait for the MRI before proceeding with dermatology evaluation, but the decision to obtain MRI depends on specific clinical and imaging features that suggest diagnostic uncertainty.

Clinical Decision Algorithm

Based on the 2025 UK Guidelines for Management of Soft Tissue Sarcomas 1, here's how to proceed:

When MRI is NOT Needed (Can Proceed Without Delay):

• Ultrasound shows classic lipoma features: homogeneous echogenic appearance, well-defined margins, no thick septations
• Small size (your lesions are 1.4 cm - relatively small)
• Superficial location with no deep fascial involvement
• No concerning features on ultrasound (no nodularity, thick septa >2mm, or solid components)

In these cases, patients can be safely reassured and managed conservatively 1. The majority of soft-tissue lumps are benign lipomas 1.

When MRI IS Indicated (Should Obtain Before Final Management):

Ultrasound is highly user-dependent, and in cases of diagnostic uncertainty, MRI of the affected region should be performed 1. Obtain MRI if:

• Deep-seated location (below deep fascia) 2
• Size >5 cm (though yours are small at 1.4 cm)
• Thick septations (>2mm) on ultrasound 2
• Increasing size over time 1
• Associated pain 1
• Uncertain ultrasound findings - which appears to be your situation since radiology recommended further characterization 1

Key Distinguishing Features

Lipoma vs. Atypical Lipomatous Tumor (ALT):

MRI features favoring ALT over benign lipoma 2:

• Tumor diameter >10 cm (91.7% of ALTs)
• Septal thickness >2mm (58% of ALTs vs 11.8% of lipomas)
• Contrast enhancement involving >1/3 of tumor volume (33.3% of ALTs vs 2% of lipomas)
• Location below deep fascia (100% of ALTs) 2

Practical Recommendation for Your Case

Given that radiology specifically recommended MRI for "further characterization," this indicates diagnostic uncertainty 1. The appropriate pathway is:

1. Proceed with dermatology referral now - don't delay the consultation
2. Obtain MRI with and without contrast as recommended, ideally before the dermatology appointment or coordinate timing with dermatology
3. If MRI shows concerning features (thick septa, deep location, nodular components, enhancement), core needle biopsy for MDM-2 amplification testing should be performed to differentiate lipoma from ALT 1

Important Caveats

• MRI cannot reliably differentiate deep lipomas from ALTs in all cases - even expert MRI review achieves only 69% accuracy 1
• The definitive test is MDM-2 amplification by fluorescence in-situ hybridization on core needle biopsy 1
• For a 59-year-old male with small (1.4 cm) posterior masses, if these are superficial and ultrasound shows typical lipoma features, observation alone may be appropriate 1
• Contrast-enhanced MRI adds minimal diagnostic value for distinguishing lipomas from ALTs according to recent 2025 data 3, though it helps identify enhancement patterns

Risk Stratification

Your patient has LOW-RISK features:

• Small size (1.4 cm)
• Multiple lesions (suggests benign process)
• Likely superficial location ("posterior soft tissue")

However, proceed with MRI because: Radiology expressed diagnostic uncertainty, which triggers the guideline recommendation for MRI 1.